The Efficacy of Dexmedetomidine for Septic Shock: A Meta-analysis of Randomized Controlled Trials

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2023 Sep 1

PMID 37657031

Authors

Xue Huang

Chunyan He

Affiliations

Soon will be listed here.

Abstract

Introduction: The efficacy of dexmedetomidine was elusive for septic shock. This meta-analysis aimed to explore the efficacy of dexmedetomidine for septic shock.

Methods: PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases have been searched through October 2022 and we included randomized controlled trials reporting the effect of dexmedetomidine in patients with septic shock.

Results: Five randomized controlled trials were included in the meta-analysis. Compared with control group for septic shock, dexmedetomidine treatment was able to substantially decrease Sequential Organ Failure Assessment score (mean difference [MD] = -0.99; 95% confidence interval [CI] = -1.14 to -0.84; P < .00001) and duration of mechanical ventilation (MD = -0.90; 95% CI = -1.27 to -0.54; P < .00001), but showed no obvious influence on morality at 28 days (odds ratio = 0.79; 95% CI = 0.38 to 1.66; P = 054), hospital mortality (odds ratio = 0.66; 95% CI = 0.35 to 1.24; P = .20) or intensive care unit length of stay (MD = -1.47; 95% CI = -4.60 to 1.66; P = .36).

Conclusions: Dexmedetomidine administration may help treat patients with septic shock.

Citing Articles

Impact of a Dexmedetomidine Intravenous Infusion in Septic Dogs: Preliminary Study.

Di Franco C, Boysen S, Vannozzi I, Briganti A Animals (Basel). 2024; 14(6).

PMID: 38539990 PMC: 10967601. DOI: 10.3390/ani14060892.

References

Geloen A, Chapelier K, Cividjian A, Dantony E, Rabilloud M, May C . Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: a pilot study. Crit Care Med. 2013; 41(12):e431-8. DOI: 10.1097/CCM.0b013e3182986248. View

Kingren M, Starr M, Saito H . Divergent Sepsis Pathophysiology in Older Adults. Antioxid Redox Signal. 2021; 35(16):1358-1375. PMC: 8905233. DOI: 10.1089/ars.2021.0056. View

Ma S, Evans R, Iguchi N, Tare M, Parkington H, Bellomo R . Sepsis-induced acute kidney injury: A disease of the microcirculation. Microcirculation. 2018; 26(2):e12483. DOI: 10.1111/micc.12483. View

De Backer D, Ricottilli F, Ospina-Tascon G . Septic shock: a microcirculation disease. Curr Opin Anaesthesiol. 2021; 34(2):85-91. DOI: 10.1097/ACO.0000000000000957. View

Lambden S, Creagh-Brown B, Hunt J, Summers C, Forni L . Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018; 22(1):174. PMC: 6035427. DOI: 10.1186/s13054-018-2102-1. View

Russell J, Rush B, Boyd J . Pathophysiology of Septic Shock. Crit Care Clin. 2017; 34(1):43-61. DOI: 10.1016/j.ccc.2017.08.005. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. PMC: 2714657. DOI: 10.1136/bmj.b2535. View

Liu J, Shi K, Hong J, Gong F, Mo S, Chen M . Dexmedetomidine protects against acute kidney injury in patients with septic shock. Ann Palliat Med. 2020; 9(2):224-230. DOI: 10.21037/apm.2020.02.08. View

Mok G, Hendin A, Reardon P, Hickey M, Gray S, Yadav K . Macrocirculatory and Microcirculatory Endpoints in Sepsis Resuscitation. J Intensive Care Med. 2020; 36(12):1385-1391. DOI: 10.1177/0885066620982585. View

10.

Chen R, Kang Z, Wang Y, Zhao J, Li S . The Anti-inflammatory Effect of Dexmedetomidine Administration on Patients Undergoing Intestinal Surgery: A Randomized Study. Drugs R D. 2021; 21(4):445-453. PMC: 8602546. DOI: 10.1007/s40268-021-00368-x. View

11.

Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B . Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2002; 345(19):1368-77. DOI: 10.1056/NEJMoa010307. View

12.

Ji F, Li Z, Nguyen H, Young N, Shi P, Fleming N . Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013; 127(15):1576-84. PMC: 3979354. DOI: 10.1161/CIRCULATIONAHA.112.000936. View

13.

He B, Zhao J, Zhang M, Quan Z . Zoledronic acid and fracture risk: a meta-analysis of 12 randomized controlled trials. Eur Rev Med Pharmacol Sci. 2021; 25(3):1564-1573. DOI: 10.26355/eurrev_202102_24865. View

14.

Lee E, Zhao L, Hsia S, Chan O, Lin C, Su Y . Vascular Reactivity Index as an Effective Predictor of Mortality in Children With Refractory Septic Shock. J Intensive Care Med. 2020; 36(5):589-596. DOI: 10.1177/0885066620914850. View

15.

Funk D, Parrillo J, Kumar A . Sepsis and septic shock: a history. Crit Care Clin. 2009; 25(1):83-101, viii. DOI: 10.1016/j.ccc.2008.12.003. View

16.

Liu X, Zhang K, Wang W, Xie G, Cheng B, Wang Y . Dexmedetomidine Versus Propofol Sedation Improves Sublingual Microcirculation After Cardiac Surgery: A Randomized Controlled Trial. J Cardiothorac Vasc Anesth. 2016; 30(6):1509-1515. DOI: 10.1053/j.jvca.2016.05.038. View

17.

Pichot C, Geloen A, Ghignone M, Quintin L . Alpha-2 agonists to reduce vasopressor requirements in septic shock?. Med Hypotheses. 2010; 75(6):652-6. DOI: 10.1016/j.mehy.2010.08.010. View

18.

Kabukcu H, Sahin N, Temel Y, Titiz T . Hemodynamics in coronary artery bypass surgery: effects of intraoperative dexmedetomidine administration. Anaesthesist. 2011; 60(5):427-31. DOI: 10.1007/s00101-010-1842-3. View

19.

Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G . Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth. 2019; 123(6):777-794. DOI: 10.1016/j.bja.2019.07.027. View

20.

Yajnik V, Maarouf R . Sepsis and the microcirculation: the impact on outcomes. Curr Opin Anaesthesiol. 2022; 35(2):230-235. DOI: 10.1097/ACO.0000000000001098. View